Atoltivimab, Maftivimab, And Odesivimab
Generic Name: atoltivimab, maftivimab, and odesivimab
Dosage form: INJECTION, SOLUTION. Active ingredients: ATOLTIVIMAB-EBGN (483.3 mg/14.5mL); MAFTIVIMAB-EBGN (483.3 mg/14.5mL); ODESIVIMAB-EBGN (483.3 mg/14.5mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, SOLUTION. Active ingredients: ATOLTIVIMAB-EBGN (483.3 mg/14.5mL); MAFTIVIMAB-EBGN (483.3 mg/14.5mL); ODESIVIMAB-EBGN (483.3 mg/14.5mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, solution.
Related Medications
Odesivimab
odesivimab
Dosage form: INJECTION, SOLUTION. Active ingredients: ODESIVIMAB (100 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dibasic Potassium Phosphate, Sepia Officinalis Juice, Lycopodium Clavatum Spore, Phosphorus, Gelsemium Sempervirens Root, Atropa Belladonna, Arsenic Trioxide, And Semecarpus Anacardium Juice
dibasic potassium phosphate, sepia officinalis juice, lycopodium clavatum spore, phosphorus, gelsemium sempervirens root, atropa belladonna, arsenic trioxide, and semecarpus anacardium juice
Weakness of memory, lassitude, exhaustion.
Lidocaine Pain Reliefing Patch
lidocaine pain reliefing patch
Amide Local Anesthetic [EPC]
Purpose Topical Anesthetic
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.